Mentally Preparing for Post-COVID Life
The psychological impact of COVID-19 can include increased stress and anxiety. Discover some tips for life after lockdown that can help you move forward.
Maternal Mental Health: What to Expect & Tools to Manage
Mental health often takes a back seat for mothers-to-be. Learn about peripartum mental health and things you can do to feel better.
Management of MDD with a Focus on PGx | Part 3: The “Other Antidepressants”
Learn how less commonly prescribed antidepressants may impact treatment decisions for major depressive disorder.
Management of MDD with a Focus on PGx | Part 2: Pharmacokinetic Considerations of First-Line Antidepressants
Learn how pharmacokinetic gene variations may impact first-line pharmacologic treatments for major depressive disorder
Management of MDD with a Focus on PGx | Part 1: Pharmacodynamic Considerations of First-Line Antidepressants
Learn how pharmacodynamic gene variations may impact first-line pharmacologic treatments for major depressive disorder.
Medicare Provides Coverage of the Genomind PGx Test
Major Advancement in Support for Mental Health Patients as Medicare Provides Coverage of the Genomind Professional PGx Express Test and the VA Extends FSS Contract to Help Soldiers and Veterans.
Updates on Treatment of Bipolar Disorders and the Excess of Childhood Onsets in the US
Join Genomind and Dr. Robert Post for a presentation on updates on the treatment of bipolar disorder.
Harmony United Psychiatric Care Enhances Behavioral Health Services with Genomind’s Precision Digital Mental Health Platform
Leading behavioral health practice Harmony United Psychiatric Care has integrated Genomind’s pharmacogenomic testing and services into Mendent EMR system.
Navigating Antidepressants: Types, How They Work & What to Expect
Genetic testing for antidepressants can help providers find types of antidepressants that may be more likely to provide effective treatment for depression.
Bipolar Disorder Treatment and Pharmacogenetic Testing
Learn what to know about bipolar disorder treatments and how genetic testing for medications can help guide these options.
Introducing GenMedPro, Genomind’s Precision Medicine Software
Learn about GenMed✓ Pro – Precision Gene-Drug Interaction Software!
Pharmacokinetic Genes in Generalized Anxiety Disorder Treatment | Part 2: UGT2B15
Learn how mutations in these genes can affect the efficacy and safety of pharmacologic treatments for generalized anxiety disorder.
Pharmacokinetic Genes in Generalized Anxiety Disorder Treatment | Part 1: CYP450
Learn how mutations in these genes can affect the efficacy and safety of pharmacologic treatments for generalized anxiety disorder.
The Role of Pharmacodynamic Genes in Generalized Anxiety Disorder Treatment
Learn how mutations in these genes may impact pharmacologic treatments for generalized anxiety disorder.
What Is Treatment Resistant Depression?
Not all treatments for depression work on everyone. Learn about treatment-resistant depression causes, criteria and treatment options.
Psychiatrist Vs. Psychologist: What is the Difference Between Mental Health Providers?
Psychiatrists and psychologists provide specialized treatment for mental health conditions. Learn the differences and similarities between these and other clinicians.
Is Drug and Alcohol Addiction Genetic?
Find out how your genotype and family history can play a part in addiction, and how genetic testing can help with treatment.
What’s New in OCD?
Join Genomind and Dr. Eric Hollander for a presentation on OCD
CEO Shawn O’Brien Interviewed on WHBQ56 Sports Radio
Shawn O’Brien joined Johnny’s Radio Happy Hour on Sports 56 to explain Mental Health Map, partnering with Kevin Love & why parents should care about their child’s genetics.
Management of Generalized Anxiety Disorder with a Focus on Pharmacogenetics
Join Genomind’s Medical Science Liaisons as they present on Management of Generalized Anxiety Disorder with a Focus on Pharmacogenetics.
CEO Shawn O’Brien Interviewed on KAHI Radio
Genomind CEO Shawn Patrick O’Brien joins Casey Freelove of KAHI Radio in Sacramento/ Auburn, CA to discuss Genomind’s tests, mission and initiatives.
Kevin Love & Genomind Join Forces to Introduce a New Expert Starting Point for Mental Wellness
Kevin Love partners with Genomind to introduce Mental Health Map, a genetic test designed to help people start their mental health and wellness journey.
Anxiety So Bad You Can’t Sleep? What To Do
Learn the ways anxiety affects your mental health, the relationship between mental health and sleep, and how to get better rest each night.
A Guide to Adult ADHD
Are you dealing with the symptoms of adult ADHD? Learn more about adult ADHD, appropriate treatments, and genetic testing for ADHD medications.
5 Factors That Can Cause A Decrease In Medication Effectiveness
The effectiveness of medication rests on more than just taking it correctly. Your genetics, lifestyle, and diet can impact medications more than you realize.
Clinical Pathological Conference
Join Genomind for a Grand Rounds Clinical Pathological Conference (CPC) Presentation
Genomind Announces Two Major Appointments
Cynthia Kilroy Named Chief Strategy & Corporate Development Officer and Stephen R Saklad, PharmD, BCCP Joins the Company’s Scientific Advisory Board.
Sleep and Its Effects On Your Body and Mind
Not getting enough sleep can affect your body and mind. Sleeplessness and mental health are closely linked, and poor sleep can increase your risk of depression or anxiety.
Monoamine Neurotransmitters and Psychopharmacology
Most psychotropic agents target monoamine neurotransmitters. Learn how these transmitters function and why they are important to psychopharmacology.
MTHFR Gene Spotlight
Learn more about the MTHFR enzyme.
